Trial intelligence / Profile preview

Bailing Capsule for chronic persistent bronchial asthma

ChiCTR1800017263Phase 4Not yet recruiting

Sponsor
Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Start
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of bailing jiaonang in asthma (2 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Asthma treatment step-down with combined medication and Asthma control level. Planned start Jan 2018; status: not yet recruiting.

02

Drugs

bailing jiaonang
03

Conditions

asthma

Beyond the preview

Go deeper on ChiCTR1800017263.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800017263.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call